What You Should Know:

– Avel eCare, the nation’s leading provider of clinician-to-clinician telemedicine services, continues its aggressive growth strategy with the acquisition of Horizon Virtual, a Minnesota-based virtual hospitalist services provider. 

– This acquisition builds upon Avel’s previous expansion, including the January 2023 acquisition of remote pharmacy services provider NightWatch. Today, Avel serves hundreds of customers across the country with a comprehensive suite of telemedicine solutions and care delivery models.

Strengthening Hospitalist Expertise

Dr. David Willardsen, former CEO of Horizon Virtual, will join Avel as Vice President of Provider Relations and Strategic Partnerships. He will play a key role in developing strategies for market expansion and forging new partnerships. Dr. Todd Severnak, formerly with Horizon Virtual, will serve as Avel’s Medical Director for the combined Hospitalist service. He will lead a team of experienced hospitalists, delivering 24/7 care to hospitals nationwide.

“This is a great strategic fit for Horizon Virtual. After more than seven years of working with critical access hospitals and medical facilities in Minnesota to help address staffing challenges and provide the appropriate physician coverage in their hospitalist areas, we can now offer our customers solutions that address multiple areas within their hospitals while continuing to provide the same world-class virtual care. It has been an honor and will continue to be my desire to serve our customers and help alleviate staffing shortages and physician burnout as it has enabled more patients to remain in their local communities near friends and family support,” says Darin Willardsen, the CEO of Horizon Virtual. 

Expanding Nationwide Reach

Horizon Virtual’s highly skilled team of internal medicine hospitalists significantly enhances Avel’s robust network of clinicians. This acquisition builds upon Avel’s previous purchases of Fident Health (September 2023) and NightWatch (January 2023), further expanding its service offerings and geographic reach.

Elevating Patient Care with 24/7 Support

Avel eCare provides hospitals across the U.S. with access to a dedicated team of board-certified hospitalists and registered nurses, available 24/7. Avel’s virtual clinicians seamlessly integrate into local medical teams, collaborating with on-site staff to deliver and coordinate high-quality patient care. Avel’s proprietary software platform simplifies communication and ensures efficient care delivery.

Avel’s Comprehensive Telemedicine Solutions

With this acquisition, Avel eCare continues to position itself as a one-stop shop for telemedicine solutions. The company now serves hundreds of customers nationwide, offering a variety of services and care delivery models to meet the evolving needs of the healthcare industry.

What You Should Know: 

– Quest Diagnostics today announced it will acquire key assets of PathAI Diagnostics, including its state-of-the-art digital pathology laboratory in Memphis, Tennessee. 

– As part of the acquisition, this facility will become Quest’s AI and digital R&D center, supporting its pathology businesses, AmeriPath, and Dermpath Diagnostics.

Digital Pathology and AI Integration

Quest will license PathAI’s AISight™ digital pathology system and AI algorithms. This will empower Quest to integrate digital pathology and AI into its existing pathology laboratories across the US. PathAI will continue to operate its independent biopharma lab, providing end-to-end clinical trial services. Quest will become a preferred provider for these services.

Unlocking the Power of Digital Pathology

Traditional cancer diagnosis relies on visual examination of tissue samples under a microscope. Digital pathology offers numerous advantages:

• Faster turnaround times: Digital slides can be shared electronically, eliminating the need for physical transportation of samples.
• Improved access to expertise: Digital slides can be reviewed by specialists remotely, regardless of location.
• Reduced workload for pathologists: AI can assist pathologists by identifying areas of concern within digital images.

“This transaction will enable Quest to dramatically ramp our capabilities in AI and digital pathology, building on our leadership in oncology and subspecialized pathology services,” said Kristie Dolan, Senior Vice President, Oncology, Quest Diagnostics. “AI and digital technologies have tremendous potential to improve cancer care, and Quest has the know-how to scale and deliver innovations that are high quality, efficient and broadly accessible. PathAI has industry-leading expertise in AI pathology innovation, and their state-of-the-art digitized laboratory in Memphis provides a platform for future growth.”

What You Should Know: 

– Aledade, the nation’s leading network of independent primary care practices, announced today the acquisition of Michigan-based Medical Advantage. 

– This strategic acquisition further solidifies Aledade’s position as the preeminent Accountable Care Organization (ACO) network and a driving force in value-based care.

Expanding Physician Partnerships in Michigan

The acquisition significantly expands Aledade’s network in Michigan, bringing the number of partnered physicians from 35 to roughly 700. This strengthens Aledade’s ability to deliver high-quality, value-based care to a wider patient population across the state.

Preserving Physician Choice and Value-Based Opportunities

Importantly, Aledade will maintain Medical Advantage’s standing as a physician organization, allowing it to participate in value-based care arrangements with various payers, including the prominent Blue Cross Blue Shield of Michigan. This ensures continued flexibility and choice for both physicians and patients.

“This is the merger of two organizations dedicated to doing what’s good for patients, practices and society,” said Farzad Mostashari, M.D., co-founder and CEO of Aledade. “Working together, we can help more independent primary care practices in Michigan not only to participate, but succeed, in value-based care. This partnership means more Michigan primary care physicians will have support in doing what they do best – keeping Michiganders healthy.”

What You Should Know: 

– Deloitte announced today the acquisition of substantially all assets belonging to Gryphon Scientific, LLC (Gryphon). Gryphon is a leader in biosafety, biosecurity, and all-hazards preparedness and response. 

– The combined expertise of Gryphon and Deloitte will fuel the development of practical AI applications in healthcare. Together, they will champion multi-sector collaboration and risk management strategies to create trustworthy AI solutions through the Federal Health AI Accelerator at Deloitte.

Acquisition IMpact for Deloitte & Its Clients

Gryphon brings a wealth of expertise to the table. Their multidisciplinary team, comprised of scientists, programmers, and policy professionals, boasts experience in data science, scientific communication, modeling, and risk assessment. This team will significantly enhance Deloitte’s ability to serve clients facing complex missions.

The acquisition benefits Deloitte’s clients in several ways:

• Enhanced Biosecurity and Public Health Preparedness: Gryphon’s expertise will bolster Deloitte’s life science and public health capabilities, allowing them to better assist clients in preparing for biological emergencies and biothreats. This will strengthen public health and safety on a national scale.
• Advanced Data Science and Risk Assessment: Gryphon’s team brings advanced data science and risk assessment skills, allowing Deloitte to provide more comprehensive solutions for clients facing complex challenges.
• Leadership in AI Safety: Gryphon is a frontrunner in AI safety, particularly regarding the evolving risk landscape of biological and chemical threats posed by AI. This expertise will be instrumental in developing practical and trustworthy AI applications through the Federal Health AI Accelerator at Deloitte.

By combining Deloitte’s extensive resources with Gryphon’s specialized knowledge, this acquisition positions them at the forefront of safeguarding public health and security in a world increasingly shaped by emerging technologies and complex global threats.

“The addition of Gryphon’s leadership and key professionals to the Deloitte team represents a significant enhancement to Deloitte’s data analytics and advanced technology capabilities. Our federal health practice is excited to lead the way for U.S. government and public services (GPS) to push the boundaries and bring our clients to the forefront of AI-enabled, mission-driven work,” said Beth Meagher, principal, Deloitte Consulting LLP and U.S. federal health sector leader. “This enhances the types of data-driven technology and scientific experience that we can offer to federal agencies and strengthens our ability to support government leaders in their efforts to safeguard the security of our nation and the health and safety of our people.”

What You Should Know: 

– ShiftMed, a leader in on-demand healthcare workforce technology acquires CareerStaff Unlimited from Genesis HealthCare, a national post-acute care provider. 

– The strategic acquisition strengthens ShiftMed’s position as the industry’s first platform to support health systems across all care settings, from hospitals to post-acute care facilities and even in-home care.

CareerStaff Acquisition Impact

The acquisition unites ShiftMed’s innovative on-demand staffing platform with CareerStaff’s established expertise as a managed service provider (MSP) in the healthcare industry. This combined offering will provide significant benefits for both ShiftMed and Genesis HealthCare:

• Enhanced Services for Genesis:  Under a seven-year exclusive agreement, ShiftMed will deliver staffing solutions to over 1,200 of Genesis’ Powerback Rehabilitation locations and more than 200 skilled nursing facilities.
• A First for On-Demand Staffing:  ShiftMed positions itself as the first platform to offer healthcare systems comprehensive on-demand staffing solutions across various care settings, including acute care, post-acute care, and even in-home care.

ShiftMed’s “Intelligent Routing” Advantage

ShiftMed’s existing technology adds an additional layer of efficiency.  Their “intelligent routing” system ensures optimal allocation of staffing needs. This system efficiently distributes open shifts among internal staff and the most cost-effective external agencies, further reducing client costs.

“The integration of CareerStaff with ShiftMed allows us to fulfill 100% of our clients’ On Demand needs through one workforce platform. By merging ShiftMed’s acclaimed mobile-first suite of products with CareerStaff’s top-tier MSP solution, we’re establishing the industry’s first end-to-end digital MSP,” said Todd Walrath, CEO of ShiftMed.

What You Should Know: 

– ABOUT Healthcare (ABOUT®), a leader in hospital operations solutions, has announced a strategic acquisition of Edgility, an AI and analytics platform company. This move signifies a significant leap forward in patient flow management, promising to optimize hospital operations and expedite patient care.

– ABOUT emphasizes that the combined platform offers the only end-to-end care orchestration solution in the market. This empowers healthcare systems to achieve their strategic goals for optimized patient flow and improved patient care.

Enhancing Care Orchestration with AI

The acquisition empowers ABOUT to integrate Edgility’s AI and analytics capabilities with their existing care orchestration technology. This creates a comprehensive “next-generation system-wide patient flow model.”  This model, spanning admission to discharge, aims to:

• Enhance Patient Progression: By leveraging predictive and prescriptive analytics, healthcare organizations can make informed decisions about patient movement through the system.
• Optimize Capacity: AI-driven decision support with clear visualizations will empower data-driven capacity management, ensuring hospitals can accommodate incoming patients efficiently.
• Accelerate Discharge Velocity: The combined solution facilitates smoother transitions between care settings, leading to faster discharge times.

Command Center Strategies for Improved Operations

The integration of Edgility empowers ABOUT to offer a holistic solution that aligns with “command center strategies” within healthcare systems. This approach connects various operational aspects, including:

• Transfers
• Admission Management
• Patient Flow
• Daily Huddles
• Discharges
• Hospital-at-home programs
• Referral Management (post-acute & behavioral health)

AI-Driven Efficiency and Reduced Errors

The combined offering from ABOUT and Edgility goes beyond data visualization. It leverages AI to automate and streamline complex healthcare tasks. This translates to:

• Improved Efficiency: Streamlined workflows free up valuable time for healthcare professionals.
• Reduced Errors and Delays: AI-powered insights minimize disruptions and delays in patient care.

“Our acquisition of Edgility completes a powerful new end-to-end care orchestration solution that connects people, data, workflows, and systems to improve outcomes and enable better coordinated care,” said Jonathan Shoemaker, CEO of ABOUT. “Health systems can now derive deep situational awareness and decision support across the patient progression at the individual and system levels, removing friction points and natural delays, ultimately improving coordination at each step of the patient journey.”

What You Should Know: 

– DrFirst has announced a strategic acquisition of Myndshft Technologies, Inc., an end-to-end real-time medical benefits and automated prior authorization (PA) software-as-a-service (SaaS).

– Myndshft software-as-a-service automates and simplifies time-consuming healthcare patient access tasks associated with prior authorization, eligibility and benefits verification, and patient financial responsibility, freeing providers and payers to concentrate more fully on patient care. Myndshft works with leading providers, payers, and health information exchanges. 

Focus on Specialty Medications and Improved Efficiency

The acquisition specifically targets the prior authorization (PA) process for specialty medications, like infusions and injectables, typically covered under medical benefits.  These medications are often critical for patient well-being, but obtaining them can be hindered by complex and time-consuming procedures.

Myndshft’s Technology: An  Automation Powerhouse

Founded in 2018, Myndshft offers a unique, unified platform that streamlines the entire PA process, leveraging:

• AI and Automation: Myndshft utilizes artificial intelligence, machine learning, and robotic process automation (RPA) to automate tasks across various payers and treatment categories.
• Seamless Workflow Integration: The platform integrates with existing systems, eliminating the need for multiple platforms and manual data entry.
• Holistic Approach: Myndshft goes beyond medications, streamlining processes for labs and imaging procedures often required before obtaining specialty medications.

Benefits for Patients, Providers, and the Healthcare System

This acquisition offers a win-win-win for patients, providers, and the healthcare system as a whole:

• Patients: Gain faster access to crucial medications through a more efficient PA process.
• Providers: Experience reduced administrative burden, allowing them to focus on delivering quality care.
• Healthcare System: Improves overall efficiency and reduces unnecessary delays and costs associated with manual PAs.

DrFirst’s Network: A Perfect Match for Widespread Adoption

DrFirst’s extensive network, encompassing over 270 EHR systems, 500,000 healthcare providers, and nearly 100 million patients, provides the ideal platform for widespread adoption of Myndshft’s technology. This integration ensures rapid scalability and accessibility across the US healthcare market.

“We were looking for the right partner with existing provider and patient workflows as well as expertise in integrating across the healthcare landscape to maximize the value of our innovative technology,” said Ron Wince, Myndshft founder and CEO. “We are excited to work within the DrFirst network to ease the administrative burden on healthcare providers and help patients access needed therapies and other services.”

What You Should Know: 

– Medicus IT, a leading national provider of healthcare technology solutions and managed services, has announced the acquisition of BlueNovo. 

– The acquisition signifies Medicus IT’s unwavering dedication to supporting community health centers. By combining their expertise and resources, both companies can work towards improving healthcare quality and accessibility for underserved communities nationwide.

BlueNovo: A Boon for Community Healthcare

BlueNovo is a renowned provider of physician and patient-centered healthcare services, quality improvement initiatives, and technology solutions specifically designed for community health centers.  This acquisition allows Medicus IT to:

• Expand Capabilities and Reach: By integrating BlueNovo’s expertise, Medicus IT broadens its service portfolio and strengthens its ability to cater to the unique needs of community health centers.
• Solidify Leadership Position: The acquisition further cements Medicus IT’s position as the go-to partner for healthcare technology solutions across the nation.

National Presence with a Local Focus

With this acquisition, Medicus IT expands its national footprint while staying true to its commitment to community-based healthcare. They already boast nine established support centers strategically located across the US, including centers of excellence in Georgia, Florida, New Jersey, North Carolina, Arizona, and Ohio. This extensive network ensures they can provide personalized and responsive support to community health centers nationwide.

“With this acquisition, we gain an exceptional team that will accelerate our ability to innovate and deliver enhanced healthcare transformation solutions while delivering the ultimate client experience. I’m thrilled about what we have accomplished, and I look forward to seeing what else we can achieve. Our success is attributed to our long-term vision and commitment to growth and excellence. This merger is another step in our journey that reaffirms Medicus as a trusted technology partner in the ever-evolving healthcare IT space, allowing us to continue our mission of delivering significant value to our clients,” said Chis Jann, CEO, Medicus IT.

What You Should Know: 

– AngelEye Health, the leading provider of technology for neonatal and pediatric family engagement services, has announced the acquisition of NICU2Home. 

– NICU2Home, dedicated to empowering families through technology during their NICU journey, perfectly complements AngelEye’s existing solutions.

A Holistic Approach to NICU Care

By integrating NICU2Home’s expertise, AngelEye expands its solutions to:

• Seamlessly connect families with their infants: Improved communication tools and resources empower families throughout the NICU journey.
• Streamline the patient experience: From admission to discharge, both families and clinicians benefit from a more efficient and coordinated care process.

Addressing the Gap in Neonatal Care Coordination

This acquisition tackles a critical challenge in NICU care – the lack of a robust system for discharge coordination. The combined solution offers several advantages:

• Optimized discharge planning and parent engagement: Ensures families are prepared and supported for the transition home.
• Enhanced communication: Streamlines information flow between care teams and families, fostering better collaboration.
• Reduced NICU stays: Improved coordination can potentially lead to shorter hospital stays for infants who are ready to go home.
• Increased hospital financial efficiency: Streamlined processes can benefit hospitals by optimizing resource allocation.

A Unified Platform for a Consolidated Experience

AngelEye plans to leverage the combined expertise to create a single, integrated platform. This will be achieved by incorporating NICU2Home’s discharge management solution into AngelEye’s existing family engagement platform.  The result? 

A consolidated experience for:

• Care teams: Enhanced workflows and improved communication with families.
• Healthcare providers: Access to a comprehensive suite of tools to support NICU care.
• Families: Streamlined access to information, resources, and communication channels.

NICU2Home’s user-friendly mobile app, backed by peer-reviewed research from four Chicago-area NICUs, including Northwestern Medicine, provides families with tools to stay informed and engaged throughout their NICU stay. It offers personalized educational content and insights that empower families to understand their child’s condition better and to engage in the care team.

The combined solution will be available in phases throughout 2024, allowing both new and existing AngelEye customers to benefit from these advancements in NICU care coordination and family engagement.

“At NICU2Home, we’ve dedicated more than twelve years to developing and refining our technology, knowing the profound impact it can have on families navigating the complexities of the NICU journey,” said Dr. Craig Garfield, co-founder and co-PI at NICU2Home. “Partnering with AngelEye, a leader in the field with a vast existing network, is a game-changer. Together, we have the potential to revolutionize NICU care by empowering families and streamlining the transition home. We’re excited to join forces and make this technology accessible to more families across the country.”

What You Should Know:

–       Accenture Federal Services has entered into an agreement to acquire Cognosante, a mission-driven provider of digital transformation and cloud modernization solutions for federal health, defense, intelligence, and civilian agencies. 

–       Founded in 2008 by Michele Kang, Cognosante has grown rapidly to become a trusted provider of innovative technology solutions with its federal government clients, including healthcare programs supporting veterans, active-duty military, patients, beneficiaries, providers, and payors. 

Accenture Federal Services Welcomes Cognosante Team: Driving Innovation and Impact for the Nation

The company boasts an outstanding record of delivery, driven by expertise in technology, capabilities in cloud modernization and migration, and exceptional program management. It is renowned for its commitment to providing excellent user experiences, enhancing accessibility and equity in healthcare, and optimizing the value of investments by the federal government.

Cognosante, with a team exceeding 1,500 individuals, will merge with Accenture Federal Services, which comprises over 14,000 members. Together, they aim to redefine work processes, tackle critical challenges, and instigate meaningful transformations. The finalization of the acquisition is contingent upon regulatory scrutiny and other customary closing requirements, with the transaction terms remaining undisclosed.

As a prominent US federal services firm and a subsidiary of Accenture LLP, Accenture Federal Services empowers the federal government to surmount obstacles, achieve superior outcomes, and establish a digitally agile, intelligent, and secure core. With a workforce exceeding 14,000, they are dedicated to advancing the vital priorities of their clients, enhancing national strength and security, and improving quality of life for citizens. Leveraging Accenture’s global network across diverse industries, they introduce commercial innovation to solutions crafted through advanced research and development, emerging technologies, and human-centered design, executed with rapidity and scalability. Together, they aid clients in generating enduring value for their personnel, clientele, and collaborators, thereby effecting positive change for the nation and its communities.

“We are continually innovating and investing to help federal agencies stay ahead of the ever-changing needs of their mission and customers,” said Accenture Federal Services CEO John Goodman. “Accenture Federal Services is excited to welcome the Cognosante team. We are truly impressed with their people, capabilities, and impact. Together, we will deliver on the promise of technology for the nation’s priorities.” 

What You Should Know: 

– ChrysCapital, India’s largest homegrown private equity (PE) firm, is reportedly exploring the sale of GeBBS Healthcare Solutions, a Los Angeles-based healthcare business process outsourcing (BPO) company. 

– This comes roughly six years after ChrysCapital acquired GeBBS in 2018. The potential $1 billion valuation reflects a significant increase from the acquisition price in 2018. This transaction could signal ChrysCapital’s strategy of entering a business, nurturing its growth, and then exiting at a healthy profit.

Potential Valuation and Gain for ChrysCapital

Multiple sources familiar with the development suggest a potential valuation of $800M to $1B for GeBBS. This would represent a significant return on investment for ChrysCapital. The firm acquired an 80% stake in GeBBS for $140 million in 2018, valuing the entire company at $175M. A sale at the reported valuation range would translate to a substantial profit for ChrysCapital.

Active M&A Landscape in Healthcare BPO

The potential sale of GeBBS highlights the active mergers and acquisitions (M&A) landscape within the Indian healthcare BPO space. Recent years have seen several big-ticket deals in this sector. Notably, EQT acquired the healthcare services arm of Hinduja Global Solutions (HGS) for ₹9,000 crore ($1.2B) in 2021, marking one of the largest PE deals in the Indian outsourcing industry. Interestingly, EQT itself is currently seeking to offload a significant minority stake in this BPO business, now known as Sagility.

What You Should Know: 

– Model N (NYSE: MODN), a leading provider of revenue optimization and compliance solutions for the life sciences and high-tech industries, has announced a definitive agreement to be acquired by Vista Equity Partners (“Vista”).

– Under the terms of the agreement, Vista will acquire all outstanding shares of Model N common stock for $30.00 per share in an all-cash transaction valued at approximately $1.25 billion.

– The transaction is expected to close in mid-2024, subject to customary approvals and clearances. Upon completion, Model N will become a privately held company and its shares will be delisted from any public stock exchange.

About Model N

Model N is a leader in revenue optimization and compliance solutions, empowering companies in the pharmaceutical, medical technology, and high-tech sectors. Their intelligent platform integrates technology, data, analytics, and expert services to provide clients with deep industry insights and control over their revenue streams.

Model N’s cloud-based solution automates pricing, incentive, and contract decisions, helping businesses scale profitability and achieve revenue growth.  Trusted by over 120 countries, their solutions are used by leading companies like Johnson & Johnson, AstraZeneca, Stryker, Seagate Technology, Broadcom, and Microchip Technology.

“We are pleased to have reached this agreement with Vista, which is the culmination of a robust sale process led by our Board of Directors with the assistance of our financial and legal advisors,” said Baljit Dail, Chairman of the Model N Board. “As the Board considered the long-term path for Model N, we unanimously determined that the transaction with Vista represents the best opportunity to deliver compelling, certain, and immediate cash value to our stockholders and is in their best interest in light of the challenges faced by Model N as a standalone public company.”

What You Should Know:

– SnapCare, a leading healthcare workforce solutions provider, has announced the acquisition of Medecipher, Inc., a cloud-based predictive analytics staffing platform.

– The strategic acquisition strengthens SnapCare’s position in the market by offering a comprehensive suite of solutions for optimized staffing across the entire care continuum.

Medecipher AI-Powered Scheduling

Medecipher’s intelligent staffing platform tackles the challenge of manual scheduling with data-driven precision. Their system utilizes research-backed algorithms to predict patient census and workload, subsequently creating optimized shift plans with the ideal mix of staff based on skillsets and patient needs. This not only reduces costs but also ensures the highest quality care by ensuring appropriate staffing levels.

Benefits of SnapCare & Medecipher Integration:

• Reduced Labor Costs: A Medecipher case study demonstrated an 8% reduction in labor costs for a busy emergency department.
• Improved Safety Outcomes: The same study showed a 68% improvement in safety outcomes, likely due to reduced understaffing.
• Increased Scheduling Efficiency: Medecipher’s technology reduces scheduling time by an impressive 77%.
• Respect for Staff Preferences: The platform honors 100% of required requests and 83% of optional preferences while adhering to all labor policies.

“Medecipher’s solution is a perfect fit with SnapCare’s new, expanded platform,” said SnapCare CEO Jeff Grant. “Combined, our suite of solutions uniquely aligns with facility priorities, optimizing for internal staffing and float pool first, with full visibility into our marketplace when needed to quickly fill any remaining open positions. With SnapCare workforce solutions, healthcare organizations will realize greater operating savings, reducing waste and inefficiency.”

What You Should Know:

– QuickMD, a leader in telehealth addiction treatment, has announced the acquisition of Project Recovery, a well-respected addiction treatment clinic in South Dakota. This strategic move strengthens QuickMD’s commitment to making high-quality addiction treatment accessible and compassionate for individuals battling substance use disorders.

– The acquisition allows QuickMD to offer a seamless continuum of care, from telehealth consultations to in-person appointments and counseling. They remain committed to providing evidence-based treatment and support services to empower individuals on their recovery journey.

Focus on Accessibility and Quality Care

Founded with the mission of revolutionizing healthcare through telehealth solutions, QuickMD prioritizes care regardless of location or socioeconomic background. This acquisition furthers that mission by expanding their reach and integrating Project Recovery’s established in-person treatment program.

Combining Strengths for a Comprehensive Approach

Project Recovery, founded by Dr. Stephen Tamang, is known for its comprehensive approach, blending medication-assisted treatment (MAT) with counseling services. By partnering with local organizations, they’ve extended their reach and provided vital services to those in need.

What You Should Know:

– Sagility, a healthcare services provider acquires BirchAI, a Seattle-based company specializing in cloud-based, AI-powered customer support solutions. This strategic move strengthens Sagility’s commitment to leveraging technology for a more efficient and impactful healthcare experience.

– The acquisition broadens Sagility’s analytics and automation-backed healthcare engagement services that it provides to large national payers, Blues plans, regional payers, health systems, medical devices and other healthcare providers. This move further advances Sagility’s vision to achieve $1B in revenue and more than double its size over the next four years. BirchAI will further propel Sagility’s delivery of healthcare operations, enhance the member and provider experience, and improve quality of care.

Combining Expertise for Stronger ROI

Founded in 2020, BirchAI is a GenAI company specializing in AI-powered customer support solutions. BirchAI’s technology focuses on transformer-based natural language processing (NLP), enabling real-time AI-powered solutions for complex healthcare transactions. This translates to:

• Reduced Operational Costs: Streamlined customer support processes lead to significant cost savings.
• Improved Efficiency: AI automates tasks, freeing up human agents for more complex interactions.
• Enhanced Customer Experience: Faster resolution times and 24/7 availability improve member and provider satisfaction.

Expanding Sagility’s Service Portfolio

Sagility already offers a wide range of healthcare engagement services, including clinical operations support, member engagement tools, and provider solutions. BirchAI’s technology further strengthens this portfolio by:

• Propelling Healthcare Operations: AI streamlines back-office processes, allowing healthcare providers to focus on patient care.
• Improving Member and Provider Experience: Automated support ensures faster responses and increased accessibility.
• Enhancing Quality of Care: By streamlining administrative tasks, healthcare providers can dedicate more time to patient well-being.

“We’re thrilled to announce this acquisition of BirchAI, which enables Sagility to build on our healthcare domain expertise and demonstrates our commitment to technology enabled transformation of the healthcare value chain. BirchAI’s generative AI capabilities will help us deliver significantly more impactful ROI to our clients,” said Ramesh Gopalan, Sagility’s Group CEO.

Financial details of the acquisition were not disclosed.